| Dr Mark Chandrahant Lakshmanan, MD | |
|
1955 Mulsanne Drive, Zionsville, IN 46077 | |
| (317) 873-4801 | |
| (317) 873-4930 |
| Full Name | Dr Mark Chandrahant Lakshmanan |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 1955 Mulsanne Drive, Zionsville, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861643926 | NPI | - | NPPES |
| 01044241A | Other | IN | INDIANA STATE MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 01044241A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Chandrahant Lakshmanan, MD 1955 Mulsanne Drive, Zionsville, IN 46077 Ph: (317) 873-4801 | Dr Mark Chandrahant Lakshmanan, MD 1955 Mulsanne Drive, Zionsville, IN 46077 Ph: (317) 873-4801 |
News Archive
​One of the challenges of understanding cancer is trying to determine the mechanisms that drive metastasis, or the process by which tumor cells are able to spread throughout the body.
A protein abundant in embryonic stem cells is now shown to be important in cancer, and offers a possible new target for drug development, report researchers from the Stem Cell Program at Children's Hospital Boston.
New research explains how speaking more than one language may translate to better mental health. A paper published by Cell Press in the March 29th issue of the journal Trends in Cognitive Sciences examines how being bilingual can offer protection from the symptoms of dementia, and also suggests that the increasing diversity in our world populations may have an unexpected positive impact on the resiliency of the adult brain.
Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR® (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not meet its primary endpoint of improving recurrence-free survival.
› Verified 2 days ago
Dr. Timothy Raymond Franson, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 11610 Weeping Willow Ct, Zionsville, IN 46077 Phone: 317-840-4600 | |
Dr. Alan E Handt, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 705 Pineview Dr, Zionsville, IN 46077 Phone: 317-873-5922 | |
Dr. Maria Rivas, MD, FACP, FACE Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 4631 Hickory Ct, Zionsville, IN 46077 Phone: 317-873-5012 | |
Dr. Kimberly Rose Gatzimos, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1650 W Oak St Ste 203, Zionsville, IN 46077 Phone: 317-873-1200 Fax: 317-873-1209 | |
Belinda J Watts, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1650 W Oak St, Ste 104, Zionsville, IN 46077 Phone: 317-873-8910 Fax: 317-873-8821 | |
Dr. Charles Thomas Benson, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 6733 Beekman Pl W, Zionsville, IN 46077 Phone: 317-769-7770 | |
Paul J Hamori, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 10801 N Michigan Rd Ste 205, Zionsville, IN 46077 Phone: 317-733-1829 |